Fred Aslan - Jul 18, 2024 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
President and CEO, Director
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
Jul 18, 2024
Transactions value $
$0
Form type
4
Date filed
7/22/2024, 08:18 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Award $0 +229K $0.00 229K Jul 22, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTV Employee Stock Option (Right to Buy) Award $0 +344K $0.00 344K Jul 18, 2024 Common Stock 344K $12.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
F2 25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.